Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Cannabinoids for Improving Pain Disability in Patients With Chronic Pain
NCT05351905Completed
- Sponsor
- University Health Network
- Start
- Nov 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic pain comparing CBD oil, CBD+THC oil and Placebo oil (3 arms). Primary endpoint: Feasibility outcomes at 1 year. Started Nov 2022; status: completed.
02
Drugs
cannabidioldronabinol
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT05351905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05351905.